GGrantIndex
← Leaderboards

Frederick Augustus Valeriote

Wayne State University

Google Scholar ↗PubMed ↗ORCID ↗
$9,013,129
Attributed
$12,610,343
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,610,343 · 7

By mechanism

R01$11,886,303 · 4
R21$588,750 · 2
U19$135,290 · 1

Top collaborators

Others in their field

Top investigators on “Pharmacology”

Research focus

PharmacologyIn VivoIn VitroStructureChemistryGrantCollaborationsWaterInterestCytotoxicityMarine Natural ProductEvaluationPoriferaSolidFoundationsFractionationSolid NeoplasmAntineoplastic AgentsMethodologyPharmaceutical PreparationsTumorDiffusionMarinesTissues

Grant awards (33)

Synthesis and Optimization of the Aleutianamine Class of Alkaloids$527,418
R01 · FY2025 · GM
UTS-1401: A Novel Mitigator of Radiation Injury$431,750
R21 · FY2025 · AI · contact PI
UTS-1401 as a Medical Countermeasure to H-ARS Consequent to a Radiation Mass Casualty$157,000
R21 · FY2025 · AI · contact PI
Synthesis and Optimization of the Aleutianamine Class of Alkaloids$530,142
R01 · FY2024 · GM
Synthesis and Optimization of the Aleutianamine Class of Alkaloids$43,500
R01 · FY2024 · GM
Synthesis and Optimization of the Aleutianamine Class of Alkaloids$532,866
R01 · FY2023 · GM
Synthesis and Optimization of the Aleutianamine Class of Alkaloids$165,660
R01 · FY2023 · GM
Synthesis and Optimization of the Aleutianamine Class of Alkaloids$560,675
R01 · FY2022 · GM
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics$636,410
R01 · FY2017 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics$640,899
R01 · FY2016 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics$644,409
R01 · FY2015 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics$63,494
R01 · FY2015 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics$38,168
R01 · FY2015 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics$626,963
R01 · FY2014 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics$82,796
R01 · FY2014 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics$678,352
R01 · FY2013 · CA
Discovery of Anticancer Drugs from Cyanophytes$354,421
R01 · FY2013 · CA · contact PI
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics$47,173
R01 · FY2013 · CA
Discovery of Anticancer Drugs from Cyanophytes$380,492
R01 · FY2012 · CA · contact PI
Discovery of Anticancer Drugs from Cyanophytes$384,028
R01 · FY2011 · CA · contact PI
Discovery of Anticancer Drugs from Cyanophytes$398,098
R01 · FY2010 · CA · contact PI
Discovery of Anticancer Drugs from Cyanophytes$411,707
R01 · FY2009 · CA · contact PI
Discovery of Anticancer Drugs from Cyanobacteria$376,635
R01 · FY2008 · CA · contact PI
Discovery/Development of Anticancer Agents from Plants$447,895
R01 · FY2007 · CA · contact PI
Discovery of Anticancer Drugs from Cyanobacteria$374,824
R01 · FY2007 · CA · contact PI
Discovery/Development of Anticancer Agents from Plants$451,761
R01 · FY2006 · CA · contact PI
Discovery of Anticancer Drugs from Cyanobacteria$376,789
R01 · FY2006 · CA · contact PI
Discovery/Development of Anticancer Agents from Plants$453,182
R01 · FY2005 · CA
Discovery of Anticancer Drugs from Cyanobacteria$376,724
R01 · FY2005 · CA
Discovery/Development of Anticancer Agents from Plants$444,003
R01 · FY2004 · CA
Discovery of Anticancer Drugs from Cyanobacteria$395,040
R01 · FY2004 · CA
Discovery/Development of Anticancer Agents from Plants$441,779
R01 · FY2003 · CA
DEVELOPMENTAL PHARMACOLOGY OF NEW ANTICANCER AGENTS$135,290
U19 · FY2000 · CA